Member Info for Bella6532

Pdub... Xxxx

The late trades are usually quite high value... But not so huge to attract too much attention...
They are definitely finding it relatively easy to shift the shares and by holding the buys back until after hours they are managing to keep the SP down as far as the wider market is concerned.
Guess we little ones will have to wait and see..

Interferon-a2b treatment for COVID-19
Eleanor N. Fish
Toronto General Hospital Research Institute
'Background
The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is
ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon-a2b in a cohort of confirmed COVID-19 cases in Wuhan,China.
Methods
In this retrospective study, 77 adults hospitalized with confirmed COVID-19 were treated with either nebulized IFN-a2b (5mU b.i.d.), arbidol (200mg t.i.d.) or a combination of IFN-a2b plus arbidol. Serial SARS-CoV-2 testing along with hematological measurements, including cell counts and blood biochemistry, serum cytokine levels,
temperature and blood oxygen saturation levels were recorded for each patient during their hospital stay.
Results
Treatment with IFN-a2b with or without arbidol significantly reduced the duration of
detectable virus in the upper respiratory tract and in parallel reduced duration of elevated blood levels for the inflammatory markers IL-6 and CRP.
Conclusion
These findings suggest that IFN-a2b should be further investigated as a therapy in COVID-19 cases. '
https://www.medrxiv.org/content/10.1101/2020.04.06.20042580v1.full.pdf

Alfista I didn't say the trades were suspicious, just that they had been made over on Nex.

In addition to our own Direct-to-PCR extraction reagents we also plan to launch Exsig™ Mag which is an RNA extraction reagent using magnetic beads for those laboratories that still wish to use the automated RNA extraction systems that they have invested in.



· High throughput COVID-19 tests will be available in bulk format with each kit containing 1,536 tests for use in 384 well format instead of the smaller 96 well plate format. This product will be very helpful for large high-throughput clinical laboratories and will launch in June 2020.



· Mobile COVID-19 testing is being evaluated using the Company's q16 instrument combined with its ExsigTM Direct reagent and genesig® COVID-19 test. Trials in clinical laboratories are expected to complete in June 2020 and this mini-laboratory combination may be used in remote locations, such as care homes.

10.4m sold through Nex Market today..

Ever hopeful... 'so why is he CEO of a Bio Science Co?'
You have to back to the PXS/SIS de merger days.
He was toast as far as Moon was concerned and as he was going to resign and move family down under it was decided he knew so much about PXS and FF they would offer him the chance of basically running PXS (what was left) from his new home. DSM calls the shots globally on mfg, sales and mktg based on the AA.

At the time of the placing the company stated Lansdown held 10% or more and were buying about 4m shares in the placing. If you do the numbers/check the holding RNSs they must have purchased a shed load more or held way over 10%....
They used the SNG placing as a means to an end...fast bucks and they have been helped because the MMs are also making by buying low and selling high. The pattern is all there on the charts. They seem to be able to shift the shares relatively easily.

He has never spoken at any conferences and certainly refuses to put his mug shot up on anything. He's a bean counter not a Dr or scientist. Plus he would never travel to Germany right now nor would he Zoom...
This is an even for O'Kennedy or DSM... Wherever they all are right now via Internet conferencing...

Already done..

Tinopener.. You're only thinking UK...

https://www.cidrap.umn.edu/news-perspective/2020/05/autopsies-covid-19-patients-reveal-clotting-concerns

Tinopener...the following is worth a read...
https://www.bmj.com/content/369/bmj.m1548/rr-6
There is no cure for covid19, so preventing the severe killer side effects is going to be key.

There is plenty of science to support what s daily dose of Fruitflow is able to maintain and in turn can lead to preventing the knock on effects such as inappropriate blood clotting leading to dvt or stroke etc.
Covid19 appears to cause inappropriate blood clots.

Alfista... On a serious note, it's not looking good for the company not to have put out any news since Dec 2019 and then for the main man to go completely silent. Now is the time for reassurance not silence.

And they can't keep up with home testing demand.. Out of stock...
https://www.randoxhealth.com/product/coronavirus-covid-19-home-testing-kit/

https://www.theguardian.com/world/2020/may/11/healthcare-firm-advised-by-owen-paterson-won-133m-coronavirus-testing-contract-unopposed

62.00 now high 62.80

or some recent gains on other CV shares moving back in....lol!!1

mmm!...RNS lodged at lunchtime??!!! or Chancellers job retention scheme anouncement...or both???

Daitom... So if there's a seller, there should also be a buyer/buyers...